Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Blueprint Medicines Corp (NQ: BPMC)
59.24 USD  -2.73 (-4.41%)
Streaming Delayed Price  /  Updated: 3:43 PM EST, Feb 25, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 545,411
Open 62.50
Bid (Size) 59.20 (2)
Ask (Size) 59.28 (1)
Prev. Close 61.97
Today's Range 58.56 - 63.31
52wk Range 60.60 - 102.98
Shares Outstanding 43,837,337
Dividend Yield N/A
Performance
YTD
-27.92%
-27.92%
1 Month
-9.43%
-9.43%
3 Month
-24.88%
-24.88%
6 Month
-22.87%
-22.87%
1 Year
-23.69%
-23.69%
Top News
More News
Blueprint Medicines to Present Updated Data from Phase 2 PIONEER Trial of Avapritinib in Patients with Indolent Systemic Mastocytosis at 2020 AAAAI Annual Meeting
-- Blueprint Medicines to host investor conference call and webcast on Monday, March 16, 2020 -- Read More
from PR Newswire
Blueprint Medicines to Present at Upcoming Investor Conferences
Blueprint Medicines Corporation (NASDAQ:BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced its participation in fireside... Read More
from PR Newswire
More News
Read More
Blueprint Medicines Reports Fourth Quarter and Full Year 2019 Financial Results
from PR Newswire
Blueprint Medicines to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020
from PR Newswire
Blueprint Medicines Announces PDUFA Date Extension for New Drug Application of Avapritinib for the Treatment of Adults with Fourth-Line Gastrointestinal Stromal Tumor
from PR Newswire
About to Buy Penny Stocks? Look at These 2 Companies First
category PFE , DCPH , DTIL , and 2 more.
from Motley Fool
Blueprint Medicines (BPMC) Q4 2019 Earnings Call Transcript
category BPMC , Market News
from Motley Fool
Notable Thursday Option Activity: BPMC, CACC, BYND
category Stocks
from Market News Video
Investors Snag BPMC 5.6% Cheaper Than Its Secondary Stock Offering
category Stocks
from Market News Video
Blueprint Medicines Enters Oversold Territory (BPMC)
category Stocks
from Market News Video
UPDATE 1-FDA approves Epizyme's treatment for rare tissue cancer
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.